These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
61 related articles for article (PubMed ID: 20829613)
1. Role of dopamine receptors in normal and tumoral pituitary corticotropic cells and adrenal cells. Boschetti M; Gatto F; Arvigo M; Esposito D; Rebora A; Talco M; Albertelli M; Nazzari E; Goglia U; Minuto F; Ferone D Neuroendocrinology; 2010; 92 Suppl 1():17-22. PubMed ID: 20829613 [TBL] [Abstract][Full Text] [Related]
2. Role of somatostatin receptors in normal and tumoral pituitary corticotropic cells. Hofland LJ; Lamberts SW; Feelders RA Neuroendocrinology; 2010; 92 Suppl 1():11-6. PubMed ID: 20829612 [TBL] [Abstract][Full Text] [Related]
3. Role of the PPAR-γ system in normal and tumoral pituitary corticotropic cells and adrenal cells. Mannelli M; Cantini G; Poli G; Mangoni M; Nesi G; Canu L; Rapizzi E; Borgogni E; Ercolino T; Piccini V; Luconi M Neuroendocrinology; 2010; 92 Suppl 1():23-7. PubMed ID: 20829614 [TBL] [Abstract][Full Text] [Related]
4. The clinical-molecular interface of somatostatin, dopamine and their receptors in pituitary pathophysiology. Ferone D; Gatto F; Arvigo M; Resmini E; Boschetti M; Teti C; Esposito D; Minuto F J Mol Endocrinol; 2009 May; 42(5):361-70. PubMed ID: 19141603 [TBL] [Abstract][Full Text] [Related]
5. Pre-clinical and clinical experiences with novel somatostatin ligands: advantages, disadvantages and new prospects. Hofland LJ; van der Hoek J; Feelders R; van der Lely AJ; de Herder W; Lamberts SW J Endocrinol Invest; 2005; 28(11 Suppl International):36-42. PubMed ID: 16625843 [TBL] [Abstract][Full Text] [Related]
7. Medical treatment in Cushing's syndrome: dopamine agonists and cabergoline. Petrossians P; Thonnard AS; Beckers A Neuroendocrinology; 2010; 92 Suppl 1():116-9. PubMed ID: 20829631 [TBL] [Abstract][Full Text] [Related]
8. The role of somatostatin and dopamine D2 receptors in endocrine tumors. Gatto F; Hofland LJ Endocr Relat Cancer; 2011 Dec; 18(6):R233-51. PubMed ID: 22135243 [TBL] [Abstract][Full Text] [Related]
9. Somatostatin and dopamine receptors as targets for medical treatment of Cushing's Syndrome. de Bruin C; Feelders RA; Lamberts SW; Hofland LJ Rev Endocr Metab Disord; 2009 Jun; 10(2):91-102. PubMed ID: 18642088 [TBL] [Abstract][Full Text] [Related]
10. Genetics of Cushing's syndrome. Yaneva M; Vandeva S; Zacharieva S; Daly AF; Beckers A Neuroendocrinology; 2010; 92 Suppl 1():6-10. PubMed ID: 20829611 [TBL] [Abstract][Full Text] [Related]
11. Dopamine receptor expression and function in human normal adrenal gland and adrenal tumors. Pivonello R; Ferone D; de Herder WW; de Krijger RR; Waaijers M; Mooij DM; van Koetsveld PM; Barreca A; De Caro ML; Lombardi G; Colao A; Lamberts SW; Hofland LJ J Clin Endocrinol Metab; 2004 Sep; 89(9):4493-502. PubMed ID: 15356054 [TBL] [Abstract][Full Text] [Related]
12. Ectopic expression of serotonin7 receptors in an adrenocortical carcinoma co-secreting renin and cortisol. Louiset E; Isvi K; Gasc JM; Duparc C; Cauliez B; Laquerrière A; Kuhn JM; Lefebvre H Endocr Relat Cancer; 2008 Dec; 15(4):1025-34. PubMed ID: 18708508 [TBL] [Abstract][Full Text] [Related]
13. New developments in the medical treatment of Cushing's syndrome. van der Pas R; de Herder WW; Hofland LJ; Feelders RA Endocr Relat Cancer; 2012 Dec; 19(6):R205-23. PubMed ID: 22936543 [TBL] [Abstract][Full Text] [Related]
14. Characteristics of recovery of adrenocortical function after treatment for Cushing's syndrome due to pituitary or adrenal adenomas. Klose M; Jørgensen K; Kristensen LØ Clin Endocrinol (Oxf); 2004 Sep; 61(3):394-9. PubMed ID: 15355458 [TBL] [Abstract][Full Text] [Related]